Augmentin Duo

Quick links to important sections

Augmentin Duo

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Augmentin Duo

Property Description
Active ingredients Amoxicillin and Clavulanic acid
Form Film-coated tablet and oral suspension
Pharmacological class Penicillin-class antibacterial (beta-Lactam/beta-Lactamase inhibitor)
General purpose Treating bacterial infections
Origin Semisynthetic

What Type of Medicine is Amoxicillin and Clavulanate?

Amoxicillin and Clavulanate Potassium is formally designated as a prescription-only, semisynthetic combination antibiotic belonging to the penicillin-class antibacterial group. It is specifically categorized as a beta-Lactam/beta-Lactamase inhibitor, a design that has been widely clinically recognized for extending the utility of Amoxicillin against resistant organisms. This formulation is included on the World Health Organization's List of Essential Medicines, underscoring its established significance in therapeutic protocols globally. The primary purpose of this medicine is the effective treatment of bacterial infections, making it distinct from treatments for viral illnesses. Other common brand names sharing this formulation include Amoclan and Moxiklav, though Augmentin Duo is often associated with specific marketed formulations.

The Composition: Amoxicillin and Clavulanic Acid

The medication is a robust, fixed-dose pairing containing two distinct active ingredients: Amoxicillin (as the trihydrate salt) and Clavulanic acid (as the potassium salt). Amoxicillin provides the direct antimicrobial action by disrupting the structural integrity of the bacterial cell wall, leading to the killing of susceptible bacteria. Crucially, Clavulanic acid is added as a beta-lactamase inhibitor—a protective agent that chemically neutralizes the bacterial enzymes responsible for destroying Amoxicillin. Pharmacological studies confirm this design's success in preserving antibiotic potency, and this mechanism confirms the drug's activity against strains that may be resistant to Amoxicillin alone. This combination is specifically beneficial in scenarios where the infecting bacteria are known or suspected to be protected by these resistance enzymes.

Available Preparations of Augmentin Duo

Augmentin Duo is exclusively intended for the oral route of administration and is supplied in two primary pharmaceutical preparations to ensure flexibility for patients. These forms typically include a film-coated tablet and a powder for oral suspension, which is mixed into a liquid before consumption. These presentations guarantee that the fixed combination of Amoxicillin and Clavulanate acid can be dependably delivered as a broad-spectrum product for oral use.

Regulatory References

  1. World Health Organization's List of Essential Medicines

What side effects are possible with Augmentin Duo?

Possible Side Effects and Safety Information

The safety profile for Augmentin Duo (amoxicillin/clavulanic acid) is characterized by adverse reactions classified by frequency and body system involvement, based on regulatory documentation.

Frequency-Classified Adverse Reactions

Adverse effects are categorized based on their reported frequency in clinical trials and post-marketing surveillance:

  • Very Common: Diarrhea.
  • Common: Mucocutaneous candidiasis, Nausea, Vomiting.
  • Uncommon: Dizziness, Headache, Indigestion, Skin rash, Pruritus, Urticaria, and moderate, reversible rises in liver enzymes (AST/ALT).
  • Rare: Reversible leucopenia (including neutropenia), Thrombocytopenia, and Erythema multiforme.

Clinically Significant and Serious Reactions

Certain reactions, though rare, are considered serious and require immediate medical attention. These include severe hypersensitivity reactions (anaphylaxis, angioedema), severe cutaneous adverse reactions (SCAR) such as Stevens-Johnson syndrome, cholestatic jaundice, and hepatitis. Other serious, infrequent reactions include Clostridioides difficile-associated diarrhea and antibiotic-associated colitis, and Drug-induced enterocolitis syndrome (DIES).

Safety Restrictions and Population Considerations

Augmentin Duo is contraindicated in patients with a history of hypersensitivity to any penicillin or a history of liver dysfunction associated with amoxicillin/clavulanic acid. Caution is necessary for patients with impaired renal function, as convulsions may occur, and for those with pre-existing hepatic impairment. Use should be avoided if infectious mononucleosis is suspected due to the increased risk of a rash.

Overdose and Emergency Response

Overdose and When to Seek Help

If an overdose of Augmentin Duo (amoxicillin/clavulanate) is suspected, urgent medical attention is required. Contact emergency services or go to the nearest hospital emergency department immediately.

Documented Overdose Symptoms

The most common symptoms following an overdose are generally gastrointestinal in nature, including nausea, vomiting, stomach cramps, and diarrhoea.

More severe manifestations can include central nervous system effects such as convulsions (seizures), which are more likely to occur in patients with pre-existing impaired kidney function or those who have received very high doses.

Renal Concerns

Overdose can affect the urinary system, leading to symptoms like cloudy urine or a greatly decreased frequency or amount of urine (oliguria/anuria). A risk of amoxicillin crystalluria exists, particularly with reduced urine output; maintaining adequate fluid intake is a standard supportive measure.

Emergency Actions

Clinical management of an overdose is symptomatic and supportive. The active ingredients, amoxicillin and clavulanate, can be removed from the bloodstream by haemodialysis if necessary.

Therapeutic Uses of Augmentin Duo

Amoxicillin and Clavulanate (Augmentin Duo) is commonly used to help with bacterial infections that present with significant symptoms, and is applied across domains where additional symptomatic support is needed. It is utilized within clinical settings that involve acute or disruptive symptom patterns across multiple bodily systems. This medication is generally used in conditions characterized by periods of heightened symptoms including acute bacterial sinusitis, painful ear infections (otitis media), community-acquired pneumonia, skin and soft tissue infections, and certain urinary tract infections. It is relevant for easing symptom clusters that may become intense, such as fever, localized pain, and inflammation. The combination is considered relevant when symptoms become more noticeable and initial support may not be sufficient, providing support that helps ease the overall symptom burden.

“It is commonly used when symptoms intensify and supportive relief is needed, contributing to easing the overall symptom load.”

Quick Fact: Support for Symptomatic Discomfort

Amoxicillin and Clavulanate supports the patient during difficult episodes by easing distress and helps improve day-to-day comfort. It is applied in settings where short-term symptom stabilization is important, is relevant for easing symptoms that create noticeable physiological strain.

Eligibility and Restrictions for Use

Who Can and Cannot Use Augmentin Duo?

Eligibility for Amoxicillin and Clavulanate (Augmentin Duo) is defined by official regulatory documentation and is strictly based on pre-existing conditions and patient history.


Absolute Contraindications

Use is strictly forbidden for individuals with a history of a serious hypersensitivity reaction (e.g., anaphylaxis) to Augmentin Duo, to any penicillin-class drug, or to any other beta-lactam antibacterial. Use is also contraindicated in patients with a history of cholestatic jaundice or hepatic dysfunction previously associated with amoxicillin/clavulanate therapy.


Conditional and Restricted Use

Population Group Regulatory Status
Severe Renal Impairment Specific high-dose and extended-release formulations are contraindicated (e.g., CrCl < 30 mL/min).
Hepatic Impairment Use requires caution and monitoring of liver function at regular intervals.
Infectious Mononucleosis Use should be avoided due to the high risk of developing a non-allergic skin rash.
Infants and Low-Weight Children Eligibility is restricted to specific low-ratio oral suspension formulations.
Pregnancy and Lactation Use is restricted and generally should be avoided unless considered essential by a physician, due to components passing into breast milk and limited controlled human data.

Age Eligibility: The medication is authorized for use in adults and pediatric patients generally over 12 weeks of age, subject to the restrictions and contraindications listed above.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Amoxicillin and Clavulanate (Augmentin Duo) is defined by its effects on the clearance of co-administered medicines and its potential to alter the functional outcome of certain drug classes. This information is derived exclusively from regulatory labels.

Pharmacokinetic Interactions (Exposure Modification)

  • Probenecid: Co-administration results in reduced renal tubular secretion of Amoxicillin, leading to officially increased and prolonged plasma concentrations of the antibiotic. This interaction is a specific consideration for patients with renal impairment.
  • Methotrexate: Co-administration may lead to an official increase and prolongation of plasma concentration of Methotrexate, which carries a documented potential risk of increased toxicity.

Pharmacodynamic and Functional Interactions

  • Oral Anticoagulants (e.g., Warfarin): Concomitant use may result in a documented abnormal prolongation of prothrombin time (INR), a factor that requires monitoring.
  • Oral Contraceptives: The medication may officially reduce the effectiveness of estrogen-containing oral contraceptives.
  • Bacteriostatic Agents: Potential exists for interference with the bactericidal action of Amoxicillin when used with other antibiotics classified as bacteriostatic agents.

Administration Timing Constraint

To optimize the absorption of Clavulanate Potassium and minimize potential gastrointestinal intolerance, administration is officially required at the start of a meal.

Mechanism of Action

Irreversible Blockade of the Bacterial Cell Wall

Amoxicillin's action is fundamentally bactericidal, meaning it exerts a bactericidal effect on susceptible bacteria. It achieves this by irreversibly inhibiting Penicillin-Binding Proteins (PBPs), which are critical bacterial enzymes responsible for building the rigid peptidoglycan layer of the cell wall. By permanently blocking this final cross-linking step, the cell loses its structural integrity, leading to a fatal cascade of osmotic instability and cell lysis (rupture).


️ Enzymatic Protection Against Resistance

The co-administered component, Clavulanic acid, functions by chemically protecting Amoxicillin by engaging the bacterial defense system. It acts as a suicide inhibitor for beta-lactamase enzymes, which are produced by resistant bacteria to hydrolyze and neutralize Amoxicillin. By irreversibly binding to and destroying these enzymes, Clavulanic acid safeguards Amoxicillin, ensuring it remains functionally active to continue its cell-wall-destroying mechanism. This synergy results in the bactericidal mechanism being applied to pathogens that produce the resistance enzyme.

Dosage and Administration Information

How to Use Augmentin Duo

Administration of Amoxicillin and Clavulanate (Augmentin Duo) is governed by instructions that define the precise route, frequency, and conditions for use. The medicine is exclusively intended for the oral route of administration.

Dosing Schedule and Timing

Adult dosing is typically structured around either a twice-daily or three-times-daily regimen. Standard adult doses are commonly prescribed as 875 mg/125 mg every 12 hours (BID) or 500 mg/125 mg every 8 hours (TID), based on the Amoxicillin/Clavulanate strength chosen. The medicine must be taken at the start of a meal to enhance the absorption of the clavulanate component and help reduce the possibility of gastrointestinal intolerance.

Treatment courses are designed for short-term use, generally maintained for a duration of 7 to 10 days. The instructions indicate that therapy should not be extended beyond 14 days without clinical review.

Preparation and Special Conditions

Feature Instruction Summary
Preparation The powdered formulation for oral suspension must be reconstituted with water at the time of dispensing and shaken well before each dose is administered.
Missed Dose If a dose is missed, it should be taken as soon as it is remembered, provided the next scheduled dose is at least four hours away.
Renal Adjustment Dosage must be adjusted in patients with severe renal impairment (CrCl < 30 mL/min), often by extending the dosing interval to every 12 or 24 hours, depending on the severity of impairment. The 875 mg tablet is generally not used in this population.

These instructions define a standardized, controlled protocol for administering the medicine, ensuring proper component absorption and adherence to established parameters across different patient populations.

Recent Clinical Evidence

Augmentin Duo: Overview of Research Findings

The combination of amoxicillin and clavulanic acid (Augmentin Duo) has been extensively studied for the treatment of bacterial infections. Clinical trials and post-marketing surveillance continue to provide data on its efficacy and safety profile, particularly in the context of growing antibiotic resistance.


Efficacy Against Resistant Strains

Augmentin Duo combines the broad-spectrum activity of amoxicillin, a penicillin-class antibiotic, with clavulanic acid, a beta-lactamase inhibitor. Research has consistently shown that the addition of clavulanic acid extends the drug's activity to cover beta-lactamase-producing bacteria, which are typically resistant to amoxicillin alone. This mechanism is critical for treating common pathogens found in infections like acute bacterial sinusitis and community-acquired pneumonia.

Core Study Outcomes

Clinical trials, including randomized controlled trials (RCTs), have evaluated the drug's effectiveness across various infection sites:

  • Acute Otitis Media (AOM) in Children: Studies comparing twice-daily (b.d.) versus three-times-daily (t.d.s.) regimens in pediatric AOM patients reported high rates of clinical success (cure) in both groups, around 94% at the end of therapy in some trials. A trend toward higher compliance and fewer adverse events was observed with the twice-daily dosing regimen.
  • Lower Respiratory Tract Infections (LRTIs): Research has examined the use of amoxicillin-clavulanate for conditions like acute exacerbation of chronic bronchitis and pneumonia, with observational studies noting high clinical recovery rates.

Safety and Special Populations

Safety data reflects that the combination is generally well-tolerated. The most frequently reported adverse events are mild and related to the gastrointestinal system, such as diarrhea and nausea. Rarely, serious events such as hepatic dysfunction and severe hypersensitivity reactions have been reported.

Recent pharmacokinetic studies have specifically investigated how the drug is processed in adolescents, confirming the drug’s profile and supporting its use in patients weighing 40 kg or more. Research is ongoing in certain pediatric and special patient populations to further detail the drug's safety and efficacy under various conditions.

Key Studies & References

  1. Label: Augmentin- amoxicillin and clavulanate potassium for suspension (US FDA DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Augmentin Duo (FAQ)


Q: How is Augmentin Duo different from regular Amoxicillin?

Augmentin Duo is a combination product that includes two active ingredients: Amoxicillin and Clavulanic acid. Amoxicillin provides the primary action by killing susceptible bacteria. Clavulanic acid acts as a protective agent, neutralizing the enzymes that resistant bacteria use to destroy Amoxicillin. This design, according to official product information, extends the drug's activity to cover bacteria that may be resistant to Amoxicillin alone.


Q: Is it common to experience stomach upset or diarrhea while taking this medicine?

Yes, gastrointestinal symptoms are the most frequently reported adverse events associated with this medication. Regulatory documents classify diarrhea as a Very Common side effect, and nausea and vomiting are classified as Common side effects. These findings align with general patient reports of stomach upset during treatment.


Q: What are the concerns about taking Augmentin Duo if a person has a history of kidney problems?

The official product information advises that caution is necessary for individuals with impaired kidney function. For patients with severe renal impairment, the regulatory information indicates that a change in the dosing regimen is necessary. Furthermore, official documents note that in patients with impaired kidney function, there is an increased potential for certain side effects, including convulsions.


Q: Is there an interaction between Augmentin Duo and gout medications like allopurinol?

Regulatory documents indicate that co-administration of allopurinol with the Amoxicillin component can increase the likelihood of allergic skin reactions. This risk is noted in the drug interaction profile.


Q: Why is Augmentin Duo sometimes prescribed when other antibiotics have failed?

This medicine is designed for use when an infection is caused by bacteria that produce beta-lactamase enzymes, which would neutralize Amoxicillin alone. The addition of Clavulanic acid helps preserve the antibiotic's potency. This unique mechanism is designed to address resistance in scenarios where Amoxicillin alone may not be sufficient.


Q: Why do some people take probiotics while on Augmentin Duo?

Regulatory information notes that diarrhea is a very common side effect of this drug, as it can affect the normal balance of bacteria in the gut. Because of this, some patients may choose to take probiotics to potentially help manage these common gastrointestinal side effects, although regulatory documents do not directly address this complementary use.


Q: What is the shelf life and storage requirement for the liquid suspension once it's mixed?

Once the powder for oral suspension has been mixed, it must be stored in the refrigerator at 2^circC to 8^circC (not frozen). The official product information specifies that any unused liquid portion must be discarded after 10 days.


Q: Can Augmentin Duo be used for infections caused by viruses?

No. Official regulatory documents classify Augmentin Duo as an antibacterial drug. It is specifically indicated only for the treatment of bacterial infections and is not effective against infections caused by viruses.


Q: Why is it important to finish the full course of Augmentin Duo?

Warnings and precautions for antibacterial drugs, as noted in regulatory materials, emphasize that completing the full prescribed treatment course is necessary. This adherence is a key factor used to reduce the development of drug-resistant bacteria over time.


Q: Are there any reported connections between Augmentin Duo and anxiety or mood changes?

The official adverse effects list does not specifically mention anxiety or mood changes as common reactions. The regulatory label does note uncommon side effects like dizziness and headache, and, rarely, reports of convulsions or hyperactivity, which are classified as nervous system effects.


Q: Is fatigue or tiredness a known side effect of Augmentin Duo?

Fatigue or general tiredness is not specifically listed as a categorized common or very common adverse reaction in official drug documents. However, certain rare but serious side effects, such as hepatic issues, can present with symptoms like fatigue.


Q: Does Augmentin Duo cause dark urine or affect liver function tests?

The medicine can cause uncommon, reversible rises in liver enzymes (AST/ALT) that are seen in blood tests. More rarely, serious side effects like yellowing of the skin or eyes (jaundice) and hepatitis have been reported, which may cause the related symptom of dark urine.


Q: Can Augmentin Duo be taken by people who have a history of liver issues?

Official information states that use is strictly contraindicated (forbidden) if a person has a history of cholestatic jaundice or hepatic dysfunction specifically linked to a prior Amoxicillin/Clavulanate treatment. For other pre-existing liver issues, use requires caution and monitoring of liver function.


Q: Is it necessary to avoid alcohol while on Augmentin Duo?

Official documents do not list a direct interaction between this medicine and alcohol. However, because the drug can cause side effects like nausea and vomiting, the possibility exists that alcohol consumption could exacerbate these existing gastrointestinal issues.


Q: Are there any dietary restrictions or foods to avoid while taking Augmentin Duo?

The only official instruction regarding food is that the medicine must be taken at the start of a meal. This is done to improve the absorption of the medicine and help minimize gastrointestinal side effects. No specific foods are restricted in the regulatory documentation.


Q: Does taking Augmentin Duo affect the results of a diabetes urine glucose test?

Yes, according to the official precautions, this drug may affect the results of certain laboratory tests that check for sugar in the urine. It is recommended that glucose tests based on enzymatic glucose oxidase reactions be used, as other methods may give falsely high results.


Q: Is the liquid suspension form of Augmentin Duo safe for someone with Phenylketonuria (PKU)?

The powder for oral suspension contains aspartame, which is a source of phenylalanine. Because phenylalanine can be harmful to individuals with Phenylketonuria (PKU), official information advises caution. An alternative dosage form, like the tablet, may be prescribed.


Q: Can Augmentin Duo cause a change in tooth color in children?

Yes, regulatory documents list tooth discoloration as a reported side effect in children. The resulting stains are typically yellow, gray, or brown, but they are generally noted to be removable with brushing or professional dental cleaning.


Q: Is it safe to take ibuprofen or acetaminophen with Augmentin Duo?

The regulatory drug interaction profile does not list a documented, specific interaction with common non-prescription pain relievers such as ibuprofen or acetaminophen (paracetamol).


Q: Does Augmentin Duo interact with any common vitamins or supplements?

The official regulatory drug label provides a detailed list of interactions with prescription drugs but does not list any specific common vitamins or supplements that are known to have a documented interaction with this medicine.


Q: Are there different strengths of Augmentin Duo, and how do they differ?

The drug is available in multiple different fixed-dose combinations of Amoxicillin and Clavulanate. These different strengths are used in specific regimens and for different patient populations based on the type and severity of the infection.


Q: Are the side effects generally the same for the tablet form and the liquid suspension?

The side effect profile in official documents summarizes adverse events for the drug combination generally, regardless of the form used. However, one difference is that the oral suspension contains aspartame, which presents a specific consideration for patients with Phenylketonuria (PKU).


Q: Does Augmentin Duo affect a person's ability to drive or operate machinery?

Regulatory documents indicate that adverse effects on the ability to drive or operate heavy machinery have not been observed. However, since the drug can cause uncommon side effects like dizziness and headache, caution is advised.


Q: Can Augmentin Duo be used to treat a dental abscess?

The drug is indicated for the treatment of various bacterial infections, including those of the ear, nose, throat, and skin structure. The specific indication for 'dental abscess' is not listed on the official regulatory label.


Q: What information should a person share with their dentist if they are taking Augmentin Duo?

A person should always inform their healthcare providers, including their dentist, about all medications they are currently taking. This is important due to potential interactions, such as those with blood thinners, and because the drug has been linked to tooth discoloration in children.


Q: Is Augmentin Duo effective against H. pylori?

The component Amoxicillin is indicated, in combination with other agents, for the treatment of H. pylori infection. However, the official regulatory label for the Augmentin Duo combination does not specifically list H. pylori treatment as an indication.


Q: Can Augmentin Duo affect laboratory blood tests other than liver enzymes?

Yes, according to official warnings, the drug is known to affect more than just liver enzymes. It can also prolong the prothrombin time (INR) when taken with oral anticoagulants, and can affect the results of tests for urine glucose.


Q: Why are people with glandular fever usually advised not to take this medicine?

Official warnings state that use should be avoided if infectious mononucleosis (glandular fever) is suspected. This is because the use of Amoxicillin-containing products in this condition is associated with a significantly increased risk of developing a non-allergic skin rash.

How should Augmentin Duo be stored and disposed of?

Storage and Disposal Requirements

Official regulations define specific storage conditions for Amoxicillin and Clavulanate Potassium based on its form (tablet or suspension).

Storage Requirements

Product Form Temperature Condition Stability and Protection
Tablets / Dry Powder Store at 20 C to 25 C (Controlled Room Temperature). Protect from moisture and store in the original, tightly closed container.
Reconstituted Suspension Refrigerate at 2 C to 8 C. Must not be frozen. Discard any unused portion after 10 days.

Handling and Disposal

The medicine, in all forms, must be stored out of the sight and reach of children.

All unused or expired product must be disposed of according to local regulatory requirements for pharmaceutical waste to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Augmentin Duo found in:

A-Z Index: